首页> 美国卫生研究院文献>Molecular and Clinical Oncology >A new optical probe for the detection of the sentinel lymph node using patent blue V dye in breast cancer: A preliminary study
【2h】

A new optical probe for the detection of the sentinel lymph node using patent blue V dye in breast cancer: A preliminary study

机译:一种使用专利蓝V染料检测乳腺癌前哨淋巴结的新型光学探针:初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study presents a novel near-infrared optical probe for the sentinel lymph node (SLN) detection in breast cancer patients, based on the recording of scattered photons. The aim of this study was to improve the detection of patent blue V (PBV), a dye routinely injected during clinical practice. A combined injection of the dye and radioactive colloid was used in the 24 patients enrolled in the study. The clinical results of the ex vivo detection of 70 dye-marked SLNs are reported, subsequent to the injection of various quantities of PBV (0.25–2 ml). The accuracy and success rate of an isotopic probe for the detection of radioactive colloid tracer, the eye visibility threshold of the surgeon and the use of a new optical probe were examined. The radio-labeled and dye-marked sentinel lymph nodes were all detected by the radio-isotopic probe, as opposed to the 75% detected by the eye visibility threshold of the surgeon. The optical probe detected all of the nodes, regardless of the volume of the dye injected. The relative PBV concentration computed by the probe facing SLNs with infravisible/visually undetectable dye-mark was relatively constant at 5.5±1.4 μmol/l. The optical detection of the sentinel lymph nodes using PBV and the probe presented in this study have the potential to reduce the false negative detection rate. This instrument is likely to provide surgeons with a simple diagnostic tool, without significantly changing their surgical procedures.
机译:本研究提出了一种新型的近红外光学探针,用于基于散布光子记录的乳腺癌患者前哨淋巴结(SLN)检测。这项研究的目的是改善对专利蓝V(PBV)的检测,该专利是在临床实践中常规注射的染料。该研究纳入的24名患者使用了染料和放射性胶体的组合注射。据报道,在注射各种量的PBV(0.25–2 ml)之后,离体检测了70个染料标记的SLN的临床结果。检查了用于放射性胶体示踪剂检测的同位素探针的准确性和成功率,外科医生的眼睛可见度阈值以及新光学探针的使用。放射性同位素标记的前哨淋巴结全部被放射性同位素探针检测,而外科医生的眼睛可见度阈值检测到的75%。光学探针检测到所有节点,无论注入的染料量如何。由具有不可见/视觉上无法检测到的染料标记的面向SLN的探针计算的相对PBV浓度相对恒定,为5.5±1.4μmol/ l。使用PBV进行前哨淋巴结的光学检测和本研究中提出的探针有可能降低假阴性检测率。该仪器很可能为外科医生提供一种简单的诊断工具,而不会显着改变其手术程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号